Comparing actionable results for breast and colorectal cancer patients across multigene panels.

For both breast cancer and colorectal cancer patients, the utilization of a multi-gene panel with more genes led to more positive results than a multi-gene panel with fewer genes, and the vast majority of additional findings occur in genes with published management guidelines.
These additional positive results can impact treatment decisions and cancer risk management, including earlier and/or more frequent screening,chemoprevention, and/or other measures.
In some cases, positive results occurred in genes not associated with the patient’s cancer diagnosis, but may still impact risk management for other cancer(s).

Authors: Kelly Fulk; Carin Espenschied; Jessica Profato; Patrick Reineke; Holly LaDuca; Robina Smith
Conference: ASCO 2017
Date: Friday, Jun 02, 2017 12:00pm - 1:00am

Read Abstract

View All Scientific Posters

Search Results